PT-141 10mg – Bremelanotide Research Peptide for Laboratory Use
What is PT-141 (Bremelanotide)?
PT-141 is a cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone (α-MSH). Unlike traditional melanotan peptides, PT-141 acts centrally on the brain to influence melanocortin pathways, making it a valuable tool for peptide research focused on receptor activation and signaling cascades. Ideal for scientists investigating melanocortin-mediated effects in controlled lab settings.
Key Benefits of PT-141 for Research
- High Specificity: Targets MC3R and MC4R receptors with minimal off-target effects, enhancing precision in studies.
- Soluble Formulation: Lyophilized powder reconstitutes easily for in vitro assays and cell culture experiments.
- Research Versatility: Explored in models related to arousal mechanisms, neuroendocrinology, and peptide-receptor interactions.
- Quality Assurance: Third-party tested for >99% purity, ensuring reliable results in laboratory applications.
PT-141 10mg Specifications
| Attribute | Details |
|---|---|
| Chemical Name | Bremelanotide Acetate |
| Molecular Formula | C50H68N14O10 |
| Molecular Weight | 1025.2 g/mol |
| Sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH |
| Form | Lyophilized Powder (10mg Vial) |
| Purity | >99% (HPLC) |
Research Applications and Dosage Guidelines
In research settings, PT-141 is typically reconstituted with bacteriostatic water for use in in vitro testing. Suggested lab protocols involve concentrations ranging from 0.1-10 μM for cell-based assays. Always follow institutional guidelines for handling research peptides. Note: These details are for educational and experimental reference only.
